Displaying 201 - 250 of 338 results
Released Company Title Industry Topic
20 Feb 2026
07:41 CET
OPTION GEREGLEMENTEERDE INFORMATIE - Openbaarmaking van een transparantiekennisgeving (Artikel 14, eerste lid van de Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen) 15101010 Telecommunications Equipment Other subject
20 Feb 2026
07:35 CET
OPTION REGULATED INFORMATION - Disclosure of a transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings) 15101010 Telecommunications Equipment Other subject
20 Feb 2026
07:30 CET
UMICORE Umicore: Full Year Results 2025 55201020 Specialty Chemicals Income
20 Feb 2026
07:30 CET
UMICORE Umicore : Résultats Annuels 2025 55201020 Specialty Chemicals Income
20 Feb 2026
07:30 CET
UMICORE Umicore: Jaarresultaten 2025 55201020 Specialty Chemicals Income
20 Feb 2026
07:30 CET
GIMV Announcement of share buyback in the context of a share purchase plan 30202010 Asset Managers and Custodians Other subject
20 Feb 2026
07:30 CET
GIMV Announcement of share buyback in the context of a share purchase plan 30202010 Asset Managers and Custodians Other subject
20 Feb 2026
07:30 CET
GIMV Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan 30202010 Asset Managers and Custodians Other subject
19 Feb 2026
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
19 Feb 2026
18:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
19 Feb 2026
10:30 CET
ONTEX GROUP EcoVadis Gold rating validates Ontex’s business sustainability commitments and performance for second year in a row 45201020 Personal Products Rating
19 Feb 2026
10:30 CET
ONTEX GROUP EcoVadis goud-beoordeling bevestigt voor tweede jaar op rij duurzaamheidsengagement en -prestaties van Ontex 45201020 Personal Products Rating
19 Feb 2026
07:29 CET
HYLORIS Hyloris Provides Update on FDA Review of Valacyclovir for Oral Suspension 20103010 Biotechnology Corporate life
19 Feb 2026
07:00 CET
ION BEAM APPLICATIONS IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India 20102010 Medical Equipment News contracts
19 Feb 2026
07:00 CET
ION BEAM APPLICATIONS IBA et Shreeji signent un accord pour quatre cyclotrons afin d’étendre la production de radiopharmaceutiques TEP en Inde 20102010 Medical Equipment News contracts
19 Feb 2026
07:00 CET
KINEPOLIS GROUP Kinepolis delivered solid results in 2025 40301010 Entertainment Commercial results
19 Feb 2026
07:00 CET
KINEPOLIS GROUP Kinepolis a réalisé des résultats solides en 2025 40301010 Entertainment Commercial results
19 Feb 2026
07:00 CET
KINEPOLIS GROUP Kinepolis boekt solide resultaten in 2025 40301010 Entertainment Commercial results
19 Feb 2026
07:00 CET
ARGENX SE argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026 20103010 Biotechnology Other subject
19 Feb 2026
07:00 CET
VGP VGP NV: Full Year Results 2025 35101010 Real Estate Holding and Development New
19 Feb 2026
07:00 CET
VGP VGP NV: Jaarresultaat 2025 35101010 Real Estate Holding and Development New
19 Feb 2026
07:00 CET
GIMV Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months 30202010 Asset Managers and Custodians Other subject
19 Feb 2026
07:00 CET
AZELIS GROUP NV JAARRESULTATEN 2025: AZELIS BOEKT STERKE KASSTROOMGROEI ONDANKS UITDAGENDE MARKTEN 50205020 Professional Business Support Services Commercial results
19 Feb 2026
07:00 CET
AZELIS GROUP NV Full-Year 2025 Results: Azelis Delivers Strong Cash Flow Growth in Challenging Markets 50205020 Professional Business Support Services Commercial results
19 Feb 2026
07:00 CET
GIMV Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months 30202010 Asset Managers and Custodians Other subject
19 Feb 2026
07:00 CET
GIMV Gimv zet sterk groeitraject voort met solide resultaten Recordinvesteringen in boekjaar van 9 maanden 30202010 Asset Managers and Custodians Other subject
18 Feb 2026
22:05 CET
NYXOAH SA Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East 20102010 Medical Equipment Other subject
18 Feb 2026
22:05 CET
NYXOAH SA Nyxoah Annonce la Signature d'un Mémorandum d'Accord avec l'Hôpital Sheikh Shakhbout Medical City afin d'Améliorer la Prise en Charge du Traitement de l'AOS et d'Accélérer l'Accès à Genio au Moyen-Orient 20102010 Medical Equipment Other subject
18 Feb 2026
18:30 CET
IEP INVEST Gereglementeerde informatie - Voorwetenschap – Overdracht van activa in het kader van voorgestelde ontbinding en vereffening van Iep Invest nv 35101010 Real Estate Holding and Development Other subject
18 Feb 2026
17:49 CET
ASCENCIO Interim statement at 31/12/2025 35102045 Retail REITs General meeting / Board Meeting
18 Feb 2026
17:49 CET
ASCENCIO Déclaration intermédiaire au 31/12/2025 35102045 Retail REITs General meeting / Board Meeting
18 Feb 2026
17:49 CET
ASCENCIO Tussentijdse verklaring op 31/12/2025 35102045 Retail REITs General meeting / Board Meeting
18 Feb 2026
16:16 CET
BANQUP GROUP Banqup and Visa enter strategic partnership to deliver integrated e-invoicing and e-payment solutions 10101010 Computer Services News contracts
17 Feb 2026
17:49 CET
CENERGY Hellenic Cables fournira des câbles inter-réseaux pour le projet éolien offshore BC-Wind en Pologne 50202010 Electrical Components News contracts
17 Feb 2026
17:48 CET
CENERGY Hellenic Cables to supply inter-array cables for the BC-Wind offshore wind project in Poland 50202010 Electrical Components News contracts
17 Feb 2026
17:45 CET
SOLVAY Participation notifications by The Goldman Sachs Group 55201000 Chemicals: Diversified Corporate life
17 Feb 2026
17:45 CET
SOLVAY Notifications de participation par The Goldman Sachs Group 55201000 Chemicals: Diversified Corporate life
17 Feb 2026
17:45 CET
SOLVAY Participatiemeldingen van The Goldman Sachs Group 55201000 Chemicals: Diversified Corporate life
17 Feb 2026
08:24 CET
TITAN S.A. Programme de rachats d'actions 50101030 Cement Other subject
17 Feb 2026
08:23 CET
TITAN S.A. Share buyback programme 50101030 Cement Other subject
16 Feb 2026
18:09 CET
GBL GBL - Transacties op GBL-aandelen 16-02-2026 30202000 Diversified Financial Services Other financial transaction
16 Feb 2026
18:08 CET
GBL GBL - Transactions sur actions propres 16-02-2026 30202000 Diversified Financial Services Other financial transaction
16 Feb 2026
18:07 CET
GBL GBL - Transactions on GBL shares 16-02-2026 30202000 Diversified Financial Services Other financial transaction
16 Feb 2026
18:00 CET
ION BEAM APPLICATIONS IBA – ACQUISITION OF OWN SHARES 20102010 Medical Equipment Legal
16 Feb 2026
18:00 CET
ION BEAM APPLICATIONS IBA – ACQUISITION D’ACTIONS PROPRES 20102010 Medical Equipment Legal
16 Feb 2026
18:00 CET
HYBRID SOFTWARE GROUP PLC Update on the share repurchase program 10101015 Software Share history
16 Feb 2026
17:45 CET
MELEXIS Melexis: update on the share buy-back program 10102010 Semiconductors Corporate life
16 Feb 2026
17:45 CET
MELEXIS Melexis: update over het aandeleninkoopprogramma 10102010 Semiconductors Corporate life
16 Feb 2026
17:40 CET
AGFA-GEVAERT Agfa provides update on payment of the receivable related to the sale of Offset Solutions division 20102010 Medical Equipment Legal
16 Feb 2026
17:40 CET
AGFA-GEVAERT Agfa geeft update over de betaling van de vordering in verband met verkoop van de Offset Solutions-divisie 20102010 Medical Equipment Legal